Literature DB >> 33462198

Investigating cytosolic 5'-nucleotidase II family genes as candidates for neuropsychiatric disorders in Drosophila (114/150 chr).

Euginia L Singgih1, Monique van der Voet1, Marlies Schimmel-Naber1, Emma L Brinkmann1, Annette Schenck1, Barbara Franke2,3.   

Abstract

Cytosolic 5'-nucleotidases II (cNT5-II) are an evolutionary conserved family of 5'-nucleotidases that catalyze the intracellular hydrolysis of nucleotides. In humans, the family is encoded by five genes, namely NT5C2, NT5DC1, NT5DC2, NT5DC3, and NT5DC4. While very little is known about the role of these genes in the nervous system, several of them have been associated with neuropsychiatric disorders. Here, we tested whether manipulating neuronal expression of cNT5-II orthologues affects neuropsychiatric disorders-related phenotypes in the model organism Drosophila melanogaster. We investigated the brain expression of Drosophila orthologues of cNT5-II family (dNT5A-CG2277, dNT5B-CG32549, and dNT5C-CG1814) using quantitative real-time polymerase chain reaction (qRT-PCR). Using the UAS/Gal4 system, we also manipulated the expression of these genes specifically in neurons. The knockdown was subjected to neuropsychiatric disorder-relevant behavioral assays, namely light-off jump reflex habituation and locomotor activity, and sleep was measured. In addition, neuromuscular junction synaptic morphology was assessed. We found that dNT5A, dNT5B, and dNT5C were all expressed in the brain. dNT5C was particularly enriched in the brain, especially at pharate and adult stages. Pan-neuronal knockdown of dNT5A and dNT5C showed impaired habituation learning. Knockdown of each of the genes also consistently led to mildly reduced activity and/or increased sleep. None of the knockdown models displayed significant alterations in synaptic morphology. In conclusion, in addition to genetic associations with psychiatric disorders in humans, altered expression of cNT5-II genes in the Drosophila nervous system plays a role in disease-relevant behaviors.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33462198      PMCID: PMC7813868          DOI: 10.1038/s41398-020-01149-x

Source DB:  PubMed          Journal:  Transl Psychiatry        ISSN: 2158-3188            Impact factor:   6.222


  46 in total

Review 1.  The art and design of genetic screens: Drosophila melanogaster.

Authors:  Daniel St Johnston
Journal:  Nat Rev Genet       Date:  2002-03       Impact factor: 53.242

2.  MicroRNAs mediate gene silencing via multiple different pathways in drosophila.

Authors:  Takashi Fukaya; Yukihide Tomari
Journal:  Mol Cell       Date:  2012-11-01       Impact factor: 17.970

3.  Novel homozygous missense mutation in NT5C2 underlying hereditary spastic paraplegia SPG45.

Authors:  Rachel Straussberg; Alexandros Onoufriadis; Osnat Konen; Yasmin Zouabi; Lior Cohen; John Y W Lee; Chao-Kai Hsu; Michael A Simpson; John A McGrath
Journal:  Am J Med Genet A       Date:  2017-09-08       Impact factor: 2.802

Review 4.  Expanding the clinical relevance of the 5'-nucleotidase cN-II/NT5C2.

Authors:  Lars Petter Jordheim
Journal:  Purinergic Signal       Date:  2018-10-25       Impact factor: 3.765

5.  Habituation Learning Is a Widely Affected Mechanism in Drosophila Models of Intellectual Disability and Autism Spectrum Disorders.

Authors:  Michaela Fenckova; Laura E R Blok; Lenke Asztalos; David P Goodman; Pavel Cizek; Euginia L Singgih; Jeffrey C Glennon; Joanna IntHout; Christiane Zweier; Evan E Eichler; Catherine R von Reyn; Raphael A Bernier; Zoltan Asztalos; Annette Schenck
Journal:  Biol Psychiatry       Date:  2019-05-09       Impact factor: 13.382

Review 6.  Shared mechanisms between Drosophila peripheral nervous system development and human neurodegenerative diseases.

Authors:  Wu-Lin Charng; Shinya Yamamoto; Hugo J Bellen
Journal:  Curr Opin Neurobiol       Date:  2014-04-22       Impact factor: 6.627

7.  NT5C2 novel splicing variant expands the phenotypic spectrum of Spastic Paraplegia (SPG45): case report of a new member of thin corpus callosum SPG-Subgroup.

Authors:  Mahmoud F Elsaid; Khalid Ibrahim; Nader Chalhoub; Ahmed Elsotouhy; Noora El Mudehki; Alice Abdel Aleem
Journal:  BMC Med Genet       Date:  2017-03-21       Impact factor: 2.103

Review 8.  Intellectual disability and autism spectrum disorders 'on the fly': insights from Drosophila.

Authors:  Mireia Coll-Tané; Alina Krebbers; Anna Castells-Nobau; Christiane Zweier; Annette Schenck
Journal:  Dis Model Mech       Date:  2019-05-13       Impact factor: 5.758

9.  Exome chip analyses in adult attention deficit hyperactivity disorder.

Authors:  T Zayats; K K Jacobsen; R Kleppe; C P Jacob; S Kittel-Schneider; M Ribasés; J A Ramos-Quiroga; V Richarte; M Casas; N R Mota; E H Grevet; M Klein; J Corominas; J Bralten; T Galesloot; A A Vasquez; S Herms; A J Forstner; H Larsson; G Breen; P Asherson; S Gross-Lesch; K P Lesch; S Cichon; M B Gabrielsen; O L Holmen; C H D Bau; J Buitelaar; L Kiemeney; S V Faraone; B Cormand; B Franke; A Reif; J Haavik; S Johansson
Journal:  Transl Psychiatry       Date:  2016-10-18       Impact factor: 6.222

10.  A Single-Cell Transcriptome Atlas of the Aging Drosophila Brain.

Authors:  Kristofer Davie; Jasper Janssens; Duygu Koldere; Maxime De Waegeneer; Uli Pech; Łukasz Kreft; Sara Aibar; Samira Makhzami; Valerie Christiaens; Carmen Bravo González-Blas; Suresh Poovathingal; Gert Hulselmans; Katina I Spanier; Thomas Moerman; Bram Vanspauwen; Sarah Geurs; Thierry Voet; Jeroen Lammertyn; Bernard Thienpont; Sha Liu; Nikos Konstantinides; Mark Fiers; Patrik Verstreken; Stein Aerts
Journal:  Cell       Date:  2018-06-18       Impact factor: 41.582

View more
  2 in total

Review 1.  Metabolic Aspects of Adenosine Functions in the Brain.

Authors:  Mercedes Garcia-Gil; Marcella Camici; Simone Allegrini; Rossana Pesi; Maria Grazia Tozzi
Journal:  Front Pharmacol       Date:  2021-05-14       Impact factor: 5.810

2.  Comprehensive Analysis of Prognostic Value and Immune Infiltration of the NT5DC Family in Hepatocellular Carcinoma.

Authors:  Rongqi Li; Rongqiang Liu; Shiyang Zheng; Wenbin Liu; Hui Li; Dewei Li
Journal:  J Oncol       Date:  2022-01-10       Impact factor: 4.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.